Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2022

Preoperative circulating fibrinogen to albumin ratio in predicting 5-year prognosis of oral cancer radical surgery
Authors: Hong Zhu, Wei Zhang, Pu Ye, Meng Wu
Neoplasma Vol.69, No.5, p.1246–1252, 2022
doi:10.4149/neo_2022_220422N441
[View Abstract]


Predictive and prognostic impact of the different features of tumor budding in stage II colorectal cancer
Authors: Yi-Tong Wang, Hong Wang, Li Hongwei, Bin Han, Zhi-Ping Yang
Neoplasma Vol.69, No.5, p.1237–1245, 2022
doi:10.4149/neo_2022_220525N557
[View Abstract]


Association between BRAF expression in circulating tumor cells and the clinical feature of patients with multiple myeloma
Authors: Ju-Xian Tang, Jia-Hui Zhang, Ke-Bing Zhou, Wang-Ting Li, Jin-Ying Wang, Qin Li, Feng-Xia Yan, Duan Xiao
Neoplasma Vol.69, No.5, p.1228–1236, 2022
doi:10.4149/neo_2022_220428N463
[View Abstract]


XIST as a valuable biomarker for prognosis and clinical parameters in diverse tumors: a comprehensive meta- and bioinformatics analysis
Authors: Mei-Jing Zhang, Zhe Yan, Jing Qin, Tian-Hang Luo, Biao Yang
Neoplasma Vol.69, No.5, p.1217–1227, 2022
doi:10.4149/neo_2022_220329N352
[View Abstract]


Decreased expression of SVEP1 is closely related to a cancer stem cell-like phenotype and poor prognosis in hepatocellular carcinoma
Authors: Wen-Chen Gong, Zhi-Qiang Han, Ming-Xi Guo, Shuai Zhao, Yu-Hong Guo, Bin Meng, Yan Sun, Lu Chen
Neoplasma Vol.69, No.5, p.1209–1216, 2022
doi:10.4149/neo_2022_220614N629
[View Abstract]


Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapy
Authors: Qiao-Xia Zhang, Yu-Ming Pan, Hong-Li Xiao, Na An, Si-Si Deng, Xin Du
Neoplasma Vol.69, No.5, p.1198–1208, 2022
doi:10.4149/neo_2022_220314N279
[View Abstract]


EFEMP2 increases the invasion ability of cervical cancer cells by promoting EMT via the Raf/MEK/ERK signaling pathway
Authors: Na Li, Guo-Xin Ji, Zi-Yan Yang
Neoplasma Vol.69, No.5, p.1185–1197, 2022
doi:10.4149/neo_2022_220117N74
[View Abstract]


SNHG9/miR-214-5p/SOX4 feedback loop regulates osteosarcoma progression
Authors: Chu-Jie Bai, Tian Gao, Jia-Yong Liu, Shu Li, Xin-Yun Wang, Zheng-Fu Fan
Neoplasma Vol.69, No.5, p.1175–1184, 2022
doi:10.4149/neo_2022_220228N218
[View Abstract]


NBR2/miR-561-5p/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK/mTOR pathway to repress glycolysis
Authors: Chang-Sheng Wang, Xiao-Bo Zhang, Xi-Tian Zhu, Rong-Sheng Chen
Neoplasma Vol.69, No.5, p.1165–1174, 2022
doi:10.4149/neo_2022_211102N1559
[View Abstract]


DDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling
Authors: Qing Han, Fei Xiao, Lili Ma, Jinmei Zhou, Lan Wang, Huang Cheng, Jingjing Zhu, Fuli Yao, Jianxin Lyu, Linyong Du
Neoplasma Vol.69, No.5, p.1154–1164, 2022
doi:10.4149/neo_2022_220316N289
[View Abstract]


lncRNA PSMB8-AS1 promotes colorectal cancer progression through sponging miR-1299 to upregulate ADAMTS5
Authors: Fang Zhao, Meng Wang, Yibin Zhang, Rujuan Su, Chenyang He, Xiao Gao, Ying Zan, Shuqun Zhang, Yuguang Ma, Chao Liu
Neoplasma Vol.69, No.5, p.1138–1153, 2022
doi:10.4149/neo_2022_220111N42
[View Abstract]


Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment
Authors: Jing Chen, Shu-Ting Huang, Jian-Guo Chen, Jian-Hui He, Wu-Mei Lin, Zhi-Hong Huang, Hai-Yan Ye, Shan-Yang He
Neoplasma Vol.69, No.5, p.1129–1137, 2022
doi:10.4149/neo_2022_220414N410
[View Abstract]


Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells
Authors: Yan Xu, Ji Zheng, Zhi-Ying Ye
Neoplasma Vol.69, No.5, p.1119–1128, 2022
doi:10.4149/neo_2022_220624N661
[View Abstract]


SPAG1 promotes the development of AML by activating the ERK/MAPK signaling pathway and affects the chemotherapy sensitivity of venetoclax
Authors: Lu Liu, Jing Liu, Xiao-Jun Liu, Meng-Han Liu, Xue-Feng Feng, Lin Yang, Jian-Min Luo
Neoplasma Vol.69, No.5, p.1108–1118, 2022
doi:10.4149/neo_2022_220415N416
[View Abstract]


SPARC induces M2 polarization of macrophages to promote proliferation, migration, and angiogenesis of cholangiocarcinoma cells
Authors: Shi-Kang Deng, Yun Jin, Yan Jin, Jun-Feng Wang
Neoplasma Vol.69, No.5, p.1101–1107, 2022
doi:10.4149/neo_2022_220324N333
[View Abstract]


Correlation between metastasis-associated gene 1 expression and tumor-associated macrophages in non-small cell lung cancer
Authors: Ke Ma, Yan-Xin Li, Qian-Qian Guo
Neoplasma Vol.69, No.5, p.1092–1100, 2022
doi:10.4149/neo_2022_220615N637
[View Abstract]


hsa_circ_0067514 suppresses gastric cancer progression and glycolysis via miR-654-3p/LATS2 axis
Authors: Shao-Feng Jiang, Rong-Rong Li
Neoplasma Vol.69, No.5, p.1079–1091, 2022
doi:10.4149/neo_2022_220225N209
[View Abstract]


BRAF inhibition promotes ER stress-mediated cell death in uveal melanoma
Authors: Yinu Zhaon, Yue Wang, Li Zhang, Weibin Wang, Thomas J. Fahey, Ke Yao
Neoplasma Vol.69, No.5, p.1070–1078, 2022
doi:10.4149/neo_2022_220428N462
[View Abstract]


HSPA5 repressed ferroptosis to promote colorectal cancer development by maintaining GPX4 stability
Authors: Ronglin Wang, Lei Hua, Peixiang Ma, Yang Song, Jie Min, Yongdong Guo, Cheng Yang, Junqiang Li, Haichuan Su
Neoplasma Vol.69, No.5, p.1054–1069, 2022
doi:10.4149/neo_2022_220331N363
[View Abstract]


Exosomes from M2 macrophages promoted glycolysis in FaDu cells by inhibiting PDLIM2 expression to stabilize PFKL
Authors: Peng Wang, Guang-Yao Li, Lei Zhou, Huai-Li Jiang, Yue Yang, Hai-Tao Wu
Neoplasma Vol.69, No.5, p.1041–1053, 2022
doi:10.4149/neo_2022_220426N455
[View Abstract]





Display #  
Results 1 - 20 of 121

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.